To ask the Secretary of State for Health and Social Care, whether he has had any recent meetings with representatives from the OCTAVE study; and what the timescale is for the publication of the findings from that study.
Departmental officials recently met with representatives of vaccines studies, including OCTAVE, to discuss the scientific evidence to support routine antibody testing for immunocompromised patients and options for a programme. The OCTAVE study of COVID-19 vaccine responses in patients with immunosuppressed conditions released preliminary data in August 2021. The OCTAVE DUO study has examined whether a third dose of COVID-19 vaccine will improve immune responses in the immunosuppressed. While results from each study will be published following submission and acceptance in an academic journal and following the peer review process, we are currently unable to confirm a specific timetable.